CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development ISSAQUAH, Wash., Sept. 08, 2021 (GLOBE NEWSWIRE) -- CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing round, led by...